Transdermal oxybutynin (oxytrol) for urinary incontinence.
Dull
Pamela
P
Department of Family Medicine, College of Medicine, Ohio State University, Columbus, Ohio, USA.
D000279:Administration, Cutaneous; D018680:Cholinergic Antagonists / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D004334:Drug Administration Schedule; D016527:Drug Costs; D006801:Humans; D008333:Mandelic Acids / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D018579:Patient Selection; D012449:Safety; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000188:drug therapy*; D014987:Xerostomia / Q000139:chemically induced
D018680:Cholinergic Antagonists; D008333:Mandelic Acids; C005419:oxybutynin